InfuSystems Holdings, Inc. (INFU) Earnings Call Analysis

AMEX · Healthcare · Medical Instruments & Supplies

22/25

Growth 5 Margin 5 Expansion 5 Platform 2 Financial 5

latest quarter score

Earnings Reports

22
InfuSystem (INFU) Q2 2026: Wound Care Revenue Jumps 154%, Anchoring Diversified Growth Path
August 04, 2026
22
InfuSystem (INFU) Q1 2026: Wound Care Revenue Jumps 112% as Compression Partnerships Accelerate Segment Mix Shift
May 07, 2026
19
InfuSystem (INFU) Q4 2025: Gross Margin Expands 260bps as Wound Care and PCDs Fuel Mix Shift
February 25, 2026
23
InfuSystem (INFU) Q3 2025: Biomedical Revenue Drops $6–7M, Margin Expansion Signals Shift to Higher-Return Segments
November 04, 2025
22
InfuSystem (INFU) Q2 2025: Gross Margin Jumps 574bps as Cash Flow Surges on Mix Shift
August 05, 2025
18
InfoSystem (INFU) Q2 2025: Margin Expands 574bps as Capital-Light Mix Drives Profit Upside
August 05, 2025
24
InfuSystem Holdings (INFU) Q1 2025: Adjusted EBITDA Surges 64%, Margin Expands to 18.2%
May 08, 2025
InfuSystem Holdings (INFU) Q4 2024: Adjusted EBITDA Margin Expands 1.0 Point Amid Strategic Growth Initiatives
March 04, 2025

Browse all companies